About Us
Overview
Corporate Governance
Board of Directors
Board Committees
Management
Careers
Technology
DNA Technology
Vaxfectin
®
Adjuvant
Products
Pipeline
VL-2397 Antifungal
VR-CHB01 for Chronic Hepatitis B Virus
Clinical Trials
Ongoing Clinical Trials
Compassionate Use
Investors
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Contact Us
Contact Info
Directions to Vical
Careers
NASDAQ | VICL
:
1.21
0.00
Investors
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Home
/
Investors
/
SEC Filings
/
SEC Filing Details
SEC Filing Details
01/26/2018
3
Initial Statement of Beneficial Ownership
About Us
Overview
Corporate Governance
Board of Directors
Board Committees
Management
Careers
Technology
DNA Technology
Vaxfectin
®
Adjuvant
Products
Pipeline
VL-2397 Antifungal
VR-CHB01 for Chronic Hepatitis B Virus
Clinical Trials
Ongoing Clinical Trials
Compassionate Use
Investors
Overview
Stock Information
News Releases
Events & Presentations
SEC Filings
Contact Us
Contact Info
Directions to Vical
Careers
© 2017 Vical Inc.
Privacy Policy
Terms of Use
Site Map
P. 858 646 1100
10390 Pacific Center Court, San Diego, California 92121
Designed by
Mentus
Powered By Q4 Inc.
5.14.0.5
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.